Labcorp (LH, Financial) has announced an expansion of its partnership with PathAI to integrate the FDA-cleared AISight Dx digital pathology platform throughout its anatomic pathology labs and hospital networks. This cloud-based platform will enable fully digital workflows, enhancing slide review, case management, and diagnostics through AI-powered image analysis. The initiative further supports Labcorp's precision medicine products and builds upon their 2019 strategic investment in PathAI. This collaboration continues to drive AI-driven clinical trial support and validation of AI-pathology solutions.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.